WO2025037249 - FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF
National phase entry is expected:
Publication Number
WO/2025/037249
Publication Date
20.02.2025
International Application No.
PCT/IB2024/057866
International Filing Date
13.08.2024
Title **
[English]
FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF
[French]
PEPTIDES CYCLIQUES CIBLANT LA FAP ET CONJUGUÉS ASSOCIÉS
Applicants **
NOVARTIS AG
Inventors
BONGARZONE, Salvatore
CAMPORESE, Davide
CLEMENTE, Gonçalo dos Santos
EHARA, Takeru
FISCHER, Matteo
GOLOSOV, Andrei Alexandrovich
GROSCHE, Philipp
HOLZER, Philipp
KARPOV, Alexei
LACAUD-BAUMLIN, Marion
LEDER, Lukas
MALO, Rafael Bermeo
MARZINZIK, Andreas
MIZUKOSHI, Yoshihide
MUNSCH, Charlie
RESCHKE, Markus Oliver
SELLNER, Holger
STACHYRA, Therese-Marie
Priority Data
63/519,599
15.08.2023
US
63/650,139
21.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 7788 | |
| EPO | Filing, Examination, Granting | 92618 | |
| Japan | Filing, Examination, Granting | 4594 | |
| South Korea | Filing, Examination, Granting | 7072 | |
| USA | Filing, Examination, Granting | 28840 |
Total:
140,912
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Described herein are cyclic peptides targeting fibroblast activation protein (FAP), and their incorporation into compounds for radioligand imaging and therapies, as well as methods and/or uses of such compounds for the imaging, treatment and/or prevention of FAP-implicated diseases and disorders.[French]
L'invention concerne des peptides cycliques ciblant la protéine d'activation des fibroblastes (FAP), et leur incorporation dans des composés pour l'imagerie et les thérapies par radioligands, ainsi que des méthodes et/ou des utilisations de tels composés pour l'imagerie, le traitement et/ou la prévention de maladies et de troubles associés à la FAP.